OSR2
Basic information
Region (hg38): 8:98944403-98952104
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OSR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 8 | 1 | 1 |
Variants in OSR2
This is a list of pathogenic ClinVar variants found in the OSR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-98948934-A-C | Benign (Jun 19, 2018) | |||
8-98949091-C-G | not specified | Uncertain significance (Feb 05, 2024) | ||
8-98949197-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
8-98949209-C-A | not specified | Uncertain significance (May 31, 2022) | ||
8-98949265-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
8-98949281-A-G | not specified | Uncertain significance (Oct 02, 2023) | ||
8-98949342-G-C | Likely benign (Jun 19, 2018) | |||
8-98949356-A-G | not specified | Uncertain significance (Oct 27, 2021) | ||
8-98949427-C-T | not specified | Uncertain significance (Feb 14, 2024) | ||
8-98951616-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
8-98951620-C-T | not specified | Likely benign (Mar 30, 2024) | ||
8-98951625-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
8-98951659-G-A | not specified | Likely benign (Mar 30, 2024) | ||
8-98951664-G-A | not specified | Uncertain significance (Apr 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OSR2 | protein_coding | protein_coding | ENST00000297565 | 3 | 7702 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.130 | 0.850 | 124591 | 0 | 3 | 124594 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 115 | 185 | 0.621 | 0.00000934 | 2054 |
Missense in Polyphen | 13 | 41.017 | 0.31694 | 476 | ||
Synonymous | -0.563 | 88 | 81.5 | 1.08 | 0.00000439 | 628 |
Loss of Function | 2.01 | 3 | 9.77 | 0.307 | 4.59e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000646 | 0.0000646 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000510 | 0.0000464 |
European (Non-Finnish) | 0.00000886 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.477
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.26
Haploinsufficiency Scores
- pHI
- 0.588
- hipred
- Y
- hipred_score
- 0.693
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.955
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Osr2
- Phenotype
- craniofacial phenotype; growth/size/body region phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; skeleton phenotype; embryo phenotype;
Zebrafish Information Network
- Gene name
- osr2
- Affected structure
- pectoral fin
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;urogenital system development;metanephros development;mesonephros development;chondrocyte differentiation;positive regulation of cell population proliferation;embryo development ending in birth or egg hatching;positive regulation of gene expression;cell differentiation;positive regulation of bone mineralization;osteoblast proliferation;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;embryonic skeletal limb joint morphogenesis;middle ear morphogenesis;odontogenesis;embryonic digit morphogenesis;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis;positive regulation of epithelial cell proliferation;roof of mouth development;embryonic skeletal joint morphogenesis;head development;bone morphogenesis;eyelid development in camera-type eye;embryonic skeletal joint development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding;metal ion binding